![Frauenfeld, Switzerland. 08th Apr, 2019. The headquarters of the Swiss Zur Rose Group in Frauenfeld, which owns the largest mail-order pharmacy in Europe, DocMorris. (for dpa: "DocMorris scares the industry with a Frauenfeld, Switzerland. 08th Apr, 2019. The headquarters of the Swiss Zur Rose Group in Frauenfeld, which owns the largest mail-order pharmacy in Europe, DocMorris. (for dpa: "DocMorris scares the industry with a](https://c8.alamy.com/comp/T50HEF/frauenfeld-switzerland-08th-apr-2019-the-headquarters-of-the-swiss-zur-rose-group-in-frauenfeld-which-owns-the-largest-mail-order-pharmacy-in-europe-docmorris-for-dpa-docmorris-scares-the-industry-with-a-million-dollar-business-with-e-prescriptions-credit-christiane-oelrichdpaalamy-live-news-T50HEF.jpg)
Frauenfeld, Switzerland. 08th Apr, 2019. The headquarters of the Swiss Zur Rose Group in Frauenfeld, which owns the largest mail-order pharmacy in Europe, DocMorris. (for dpa: "DocMorris scares the industry with a
![Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz](https://www.gleisslutz.com/sites/default/files/gleiss_lutz_rechtanwaelte_news_healthcare_2.jpg)
Gleiss Lutz advises Zur Rose Group on the establishment of the Doc Morris Adipositas Care portal | Gleiss Lutz
![ACXIT Capital Partners advised Zur Rose Group on the successful placement of CHF 175M Convertible Bonds - ACXIT Capital Partners ACXIT Capital Partners advised Zur Rose Group on the successful placement of CHF 175M Convertible Bonds - ACXIT Capital Partners](https://www.acxit.com/en/wp-content/uploads/2020/03/2020_03_Zur-Rose_Convertible-Financing_2.jpg)
ACXIT Capital Partners advised Zur Rose Group on the successful placement of CHF 175M Convertible Bonds - ACXIT Capital Partners
![Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium](https://miro.medium.com/max/883/1*OsdCJ9aFtgptgdKxnurrEQ.jpeg)
Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium
![The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://l450v.alamy.com/450v/2cmtct6/the-logo-of-swiss-based-mail-order-pharmacy-and-medical-supplier-zur-rose-group-is-seen-at-the-companys-headquarters-in-frauenfeld-switzerland-may-9-2017-reutersarnd-wiegmann-2cmtct6.jpg)
The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg)